Prolactogenic effects of risperidone in male patients - a preliminary study

被引：40

作者：

Shiwach, RS

Carmody, TJ

机构：

[1] Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75235 USA

[2] Univ Texas, SW Med Ctr, Acad Comp Serv, Dallas, TX USA

来源：

ACTA PSYCHIATRICA SCANDINAVICA | 1998年 / 98卷 / 01期

关键词：

prolactin; dopamine; risperidone; testosterone;

D O I：

10.1111/j.1600-0447.1998.tb10046.x

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

This preliminary study describes a case of a male patient who developed gynaecomastia and sexual difficulties whilst taking risperidone for chronic paranoid schizophrenia. Laboratory tests showed raised prolactin levels and depressed testosterone levels which were reversed on cessation of medication. A small study was subsequently conducted on male psychotic patients to compare the prolactogenic effects of risperidone (n=14) with traditional antipsychotic medication (n=15). The results showed a greater but non-significant prolactogenic effect of risperidone.

引用

页码：81 / 83

页数：3

共 14 条

[1]

CHOUINARD G, 1993, J CLIN PSYCHOPHARM, V13, P25

[2]

Cohen J, 1989, STAT POWER ANAL BEHA

[3]

COSTALL B, 1975, NEUROPHARMACOLOGY, V14, P859, DOI 10.1016/0028-3908(75)90114-8

[4]

DICKSON RA, 1995, AM J PSYCHIAT, V152, P1102

[5] POSITRON EMISSION TOMOGRAPHY STUDIES ON D-2 AND 5-HT2 RECEPTOR-BINDING IN RISPERIDONE-TREATED SCHIZOPHRENIC-PATIENTS [J].

FARDE, L ;

NYBERG, S ;

OXENSTIERNA, G ;

NAKASHIMA, Y ;

HALLDIN, C ;

ERICSSON, B .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (01) :S19-S23

[6]

FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538

[7] PROLACTIN AND NEUROLEPTIC DRUGS [J].

GREEN, AI ;

BROWN, WA .

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1988, 17 (01) :213-223

[8] DRUGS AND IMPAIRED MALE SEXUAL FUNCTION [J].

HOROWITZ, JD ;

GOBLE, AJ .

DRUGS, 1979, 18 (03) :206-217

[9] PHARMACOKINETICS OF THE NOVEL ANTIPSYCHOTIC AGENT RISPERIDONE AND THE PROLACTIN RESPONSE IN HEALTHY-SUBJECTS [J].

HUANG, ML ;

VANPEER, A ;

WOESTENBORGHS, R ;

DECOSTER, R ;

HEYKANTS, J ;

JANSEN, AAI ;

ZYLICZ, Z ;

VISSCHER, HW ;

JONKMAN, JHG .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (03) :257-268

[10]

HYMAN SE, 1991, HDB PSYCHIAT DRUG TH, P8

← 1 2 →